Summary:
Evaluation of the long-term safety, tolerability, and pharmacokinetics of cariprazine in patients with schizophrenia.
Qualified Participants Must:
• Be 18 to 60 years of age
•
Be diagnosed with schizophrenia
•
Be able to stay in a hospital setting for 14 days
• Be in good physical health
•
Have a body mass index (BMI) between 18 and 40
Qualified Participants May Receive:
Doctors visits, study medications, study evaluations, and compensation for time and travel.